| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| PRIN2022 - PRIN bando 2022 |
Decoding distinctive features of EXtracellular vesicles In TDP-43 proteinopathies - EXIT
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Endometriosis and related pain: novel pathogenetic targets for non-hormonal drugs
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Characterization of pharmacological approaches to counteract the neuropathological, morphological and behavioral alterations induced by anti-GluA3 IgG in Frontotemporal Dementia
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Early social adversity and risk for psychiatric disorders: shedding light on the therapeutic potential of psilocybin
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
The crosstalk between brain and periphery in maladaptive feeding behaviors: Role of the transcriptional repressors histone deacetylases and their therapeutic opportunities
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
SLC15A4 (Solute Carrier 15 member A4): integrated in vitro-in vivo analysis and functional characterization
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Attenuating the stress of the endoplasmic reticulum as a strategy to cure the multi-minicore disease
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Targeting hepatitis B virus with PROTAC capsid degraders (TarPaB)
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Immunoregulatory paths of metabolic disease: unveil molecular mechanisms of impaired immuno-vascular response to target visceral inflammation by rewiring regulatory T cell energetic circuits
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Organic cation transporters relevant to drug discovery: multifaceted approaches to unravel their structure/function relationships with the aim of identifying novel substrates and inhibitors enabling their application in therapy
|
|
Ongoing | 2023 |
